Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 37Terminated 10Recruiting 10Active not recruiting 6Withdrawn 2Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 25Lung Neoplasms 8Mesothelioma, Malignant 4Neoplasms 2Neoplasm Metastasis 2Mesothelioma 2Advanced Non-squamous Non-small-cell Lung Cancer 2Uterine Cervical Neoplasms 1Solitary Fibrous Tumor, Pleural 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Head and Neck Neoplasms 1Glioma 1Esophagogastric Cancer 1Colorectal Neoplasms 1Advanced Solid Tumors 1

Interventions

Cisplatin 9pembrolizumab 7Radiosurgery 6Gemcitabine 6Paclitaxel 5Dexamethasone 5Taxes 4Carboplatin 4trametinib 3ibrutinib 3Surveys and Questionnaires 3Standard of Care 3Radiotherapy 3Nivolumab 3Magnetic Resonance Spectroscopy 3Lenalidomide 3Fluorouracil 3Erlotinib Hydrochloride 3Blood Specimen Collection 3Ascorbic Acid 3venetoclax 2veliparib 2tocilizumab 2pazopanib 2obinutuzumab 2naquotinib 2lenvatinib 2fludarabine 2enzalutamide 2Vemurafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Neoplasms × Pemetrexed × Clear all
NCT02947113 2017-11-30

HYPOLAN

The Netherlands Cancer Institute

Phase 2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01567384 2013-11-20

A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies

Emory University

Phase 1 Withdrawn
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡